Title | Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance. |
Publication Type | Journal Article |
Year of Publication | 2017 |
Authors | Shukla S, Cyrta J, Murphy DA, Walczak EG, Ran L, Agrawal P, Xie Y, Chen Y, Wang S, Zhan Y, Li D, Wong EWP, Sboner A, Beltran H, Mosquera JMiguel, Sher J, Cao Z, Wongvipat J, Koche RP, Gopalan A, Zheng D, Rubin MA, Scher HI, Chi P, Chen Y |
Journal | Cancer Cell |
Volume | 32 |
Issue | 6 |
Pagination | 792-806.e7 |
Date Published | 2017 Dec 11 |
ISSN | 1878-3686 |
Keywords | Animals, Drug Resistance, Neoplasm, Gene Expression Regulation, Neoplastic, Hepatocyte Nuclear Factor 1-alpha, Hepatocyte Nuclear Factor 4, Heterografts, Humans, Male, Mice, Mice, SCID, Prostatic Neoplasms, Castration-Resistant, Trypsin Inhibitor, Kazal Pancreatic |
Abstract | Prostate cancer exhibits a lineage-specific dependence on androgen signaling. Castration resistance involves reactivation of androgen signaling or activation of alternative lineage programs to bypass androgen requirement. We describe an aberrant gastrointestinal-lineage transcriptome expressed in ∼5% of primary prostate cancer that is characterized by abbreviated response to androgen-deprivation therapy and in ∼30% of castration-resistant prostate cancer. This program is governed by a transcriptional circuit consisting of HNF4G and HNF1A. Cistrome and chromatin analyses revealed that HNF4G is a pioneer factor that generates and maintains enhancer landscape at gastrointestinal-lineage genes, independent of androgen-receptor signaling. In HNF4G/HNF1A-double-negative prostate cancer, exogenous expression of HNF4G at physiologic levels recapitulates the gastrointestinal transcriptome, chromatin landscape, and leads to relative castration resistance. |
DOI | 10.1016/j.ccell.2017.10.008 |
Alternate Journal | Cancer Cell |
PubMed ID | 29153843 |
PubMed Central ID | PMC5728174 |
Grant List | R01 CA193837 / CA / NCI NIH HHS / United States P50 CA092629 / CA / NCI NIH HHS / United States P30 CA008748 / CA / NCI NIH HHS / United States K08 CA140946 / CA / NCI NIH HHS / United States R01 CA208100 / CA / NCI NIH HHS / United States DP2 CA174499 / CA / NCI NIH HHS / United States K08 CA151660 / CA / NCI NIH HHS / United States U01 CA111275 / CA / NCI NIH HHS / United States P50 CA140146 / CA / NCI NIH HHS / United States |